55 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
of $0.0001 per share of common stock, subject to beneficial ownership limitations). The holders of a majority in voting power of the shares of common stock … , the affirmative vote of the majority of votes cast affirmatively or negatively (excluding abstentions) is required for approval. This is a routine proposal so we do
SC TO-I
EX-99
1dj2d
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
0ve7t3y 4nt55y
30 Jan 24
Issuer tender offer statement
7:04am
424B3
0jxi3luf2e ea
28 Nov 23
Prospectus supplement
4:01pm
8-K
EX-10.1
9835x
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-99.1
zzqlh6
3 Aug 23
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
fwyep3v5r1egg
4 May 23
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2023 Financial Results
4:05pm